---
title: "OptimizeRx names Andy D'Silva CFO effective Jan. 1, 2027"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295703591.md"
description: "OptimizeRx appointed Andy D'Silva as CFO effective Jan. 1, 2027, succeeding Ed Stelmakh, who remains in a strategic role through 2027. Heather Favazza was named chief accounting officer on the same date, bringing eight years of experience as corporate controller."
datetime: "2026-08-12T20:11:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295703591.md)
  - [en](https://longbridge.com/en/news/295703591.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295703591.md)
generator: "portal-rs"
---

# OptimizeRx names Andy D'Silva CFO effective Jan. 1, 2027

-   OptimizeRx named Andy D’Silva chief financial officer, effective Jan. 1, 2027, succeeding Ed Stelmakh. \* D’Silva previously served as chief business officer, covering financial strategy, capital allocation, investor relations, corporate development, long-range planning. \* Heather Favazza was appointed chief accounting officer, effective Jan. 1, 2027. \* Favazza has served as corporate controller for eight years, overseeing accounting operations, financial reporting, internal controls, compliance. \* Stelmakh will remain chief financial and strategy officer through Dec. 31, 2026, then serve as strategic adviser through end-2027. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OptimizeRx Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608121605PRIMZONEFULLFEED9808249) on August 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [OPRX.US](https://longbridge.com/en/quote/OPRX.US.md)

## Related News & Research

- [OptimizeRx Partners With PulsePoint to Expand Programmatic Access to EHR Advertising](https://longbridge.com/en/news/303222774.md)
- [Analyst Reaffirms Buy on OptimizeRx, Citing Strong Second-Half Ramp and Intact 2027 Outlook](https://longbridge.com/en/news/300826902.md)
- [Microsoft Just Revealed a $677 Billion Reason to Buy Its Stock](https://longbridge.com/en/news/303993065.md)
- [AEHR: Record $33.0m quarter; FY27 revenue outlook raised to $150m on strong AI demand](https://longbridge.com/en/news/304010185.md)
- [Historic $115B tech deal could transform the future of AI connectivity](https://longbridge.com/en/news/304022170.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**